Willingness to Pay (WTP) for COVID-19 Vaccine Booster Dose and Its Determinants in Indonesia

Author:

Harapan HarapanORCID,Sallam MalikORCID,Fathima Raisha,Kusuma Hendrix IndraORCID,Anwar SamsulORCID,Nalapraya Widhy Yudistira,Wibowo AdityoORCID,Kumara Wati Ketut Dewi,Medina Ayunda,Defrita Anna Hanifa,Astri Yesi,Prasetyowati Arie,Nurfarahin Nurfarahin,Khusna Afriyani,Oktariana Setya,Anwar Sarifuddin,Yussar Milza Oka,Khotimah SitiORCID,Maria Nainggolan Bahagia WillibrordusORCID,Amalia Badri Putri Rizki,Argarini RadenORCID,Winardi WiraORCID,Sharun KhanORCID,Indah Rosaria,Rajamoorthy YogambigaiORCID,Wagner Abram L.ORCID,Mudatsir MudatsirORCID

Abstract

Willingness to pay (WTP) for booster doses of coronavirus disease 2019 (COVID-19) vaccines is an under studied research topic. Therefore, the current study aimed to investigate the WTP for the booster doses of COVID-19 vaccines and its predictors in Indonesia using an online survey distributed all over the provinces of this low-middle-income country. The WTP was evaluated using a basic dichotomous contingent valuation approach, and its associated determinants were evaluated using a linear regression model. Out of 2935 responders, 66.2% (1942/2935) were willing to pay for a booster dose of the COVID-19 vaccine. The majority of respondents (63.5%) were willing to pay within a price range of 100,000–500,000 Indonesian rupiah (IDR), i.e., USD 6.71–33.57. Being older than 40 years, having a higher educational level, having a higher income, knowing and understanding that booster doses were important, and having a vaccine status that is certified halal (permissible in Islamic law), were all associated with a higher WTP for the booster dose of COVID-19 vaccines. The study findings imply that the WTP for a booster dose of COVID-19 vaccination in Indonesia is lower compared to acceptance of vaccines provided free of charge. This WTP data can be utilized to develop a pricing scheme for the booster doses of COVID-19 vaccination in the country with potential benefits in other low-income countries. The government may be required to provide subsidies for the herd immunity vaccination process to proceed as anticipated. Furthermore, the public community must be educated on the importance of vaccination as well as the fact that the COVID-19 epidemic is far from being over.

Funder

Indonesian Ministry of Education, Culture, Research, and Technology

Publisher

MDPI AG

Subject

Infectious Diseases

Reference82 articles.

1. World Health Organization (2022, September 19). Interim Statement on the Use of Additional Booster Doses of Emergency Use Listed mRNA Vaccines against COVID-19, Available online: https://www.who.int/news/item/17-05-2022-interim-statement-on-the-use-of-additional-booster-doses-of-emergency-use-listed-mrna-vaccines-against-covid-19.

2. An outbreak caused by the SARS-CoV-2 Delta (B. 1.617. 2) variant in a care home after partial vaccination with a single dose of the COVID-19 vaccine Vaxzevria, London, England, April 2021;Williams;Eurosurveillance,2021

3. Cruickshank, S. (2022, September 19). COVID-19 Vaccine Boosters: Is a Third Dose Really Needed?. Available online: https://www.gavi.org/vaccineswork/covid-19-vaccine-boosters-third-dose-really-needed?gclid=CjwKCAjwg5uZBhATEiwAhhRLHuoOPTT5qB2k-B5OmIG1ejyjaHGDJZ2dcXS5Z42AFeylcA5QBhqsXBoCu7kQAvD_BwE.

4. World Health Organization (2022, September 19). Interim Statement on Booster Doses for COVID-19 Vaccination, Available online: https://www.who.int/news/item/04-10-2021-interim-statement-on-booster-doses-for-covid-19-vaccination.

5. Protection against SARS-CoV-2 after Covid-19 vaccination and previous infection;Foulkes;N. Engl. J. Med.,2022

全球学者库

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"全球学者库"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前全球学者库共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2023 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3